Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

acute lung injury News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

Research reveals that inhalable carrier-free self-assembled nanoaggregates of leonurine and ursolic acid can improve outcomes in acute lung injury by targeting the TLR4/MyD88-NET signaling pathway. This study contributes to the understanding of potential therapeutic strategies for lung injuries.

Research reveals that an intranasal nanoparticle targeting the ORAI1 protein in neutrophils can reduce acute lung injury associated with pancreatitis and sepsis. This discovery may open new avenues for therapeutic interventions in these conditions.

A recent case-crossover study published in PubMed examines the relationship between direct oral anticoagulant consumption and the risk of acute interstitial lung diseases. The findings contribute to understanding potential risks associated with anticoagulant therapies.

Not rare diseases news,news about your rare disease.

Earlier

Research reveals that inhalable carrier-free self-assembled nanoaggregates of leonurine and ursolic acid can improve outcomes in acute lung injury by targeting the TLR4/MyD88-NET signaling pathway. This study contributes to the understanding of potential therapeutic strategies for lung injuries.

Research reveals that an intranasal nanoparticle targeting the ORAI1 protein in neutrophils can reduce acute lung injury associated with pancreatitis and sepsis. This discovery may open new avenues for therapeutic interventions in these conditions.

A recent case-crossover study published in PubMed examines the relationship between direct oral anticoagulant consumption and the risk of acute interstitial lung diseases. The findings contribute to understanding potential risks associated with anticoagulant therapies.

Not rare diseases news,
news about your rare disease.